Rifampin (also known as rifampicin) is an antibiotic belonging to the rifamycin class. It is widely used to treat bacterial infections such as tuberculosis (TB) and to prevent the spread of certain bacteria after exposure. The medication is available as a pill in strengths of 150 mg, 300 mg, 450 mg, and 600 mg. In Hong Kong, Rifampin is a prescription-only drug regulated by the Department of Health and must be dispensed by a licensed pharmacist.
Rifampin inhibits bacterial DNA-dependent RNA polymerase, an enzyme essential for transcription of bacterial DNA into messenger RNA. By blocking this step, the drug prevents the synthesis of proteins needed for bacterial growth and replication. The inhibition is bactericidal, meaning it kills actively dividing bacteria rather than merely stopping their growth.
Key pharmacologic points:
Rifampin is approved by major regulatory agencies (including the U.S. FDA and the European EMA) for the following indications, which are also reflected in Hong Kong clinical practice guidelines:
These uses are based on robust clinical trial data and are incorporated into the Hong Kong Tuberculosis Control Programme.
Rifampin is sometimes employed in clinical situations that are not part of its formal labeling but have supporting evidence:
Disclaimer: Off-label use requires careful medical supervision, individualized risk assessment, and should follow up-to-date clinical guidelines.
Patients with a history of hemolytic anemia, especially those with glucose-6-phosphate dehydrogenase (G6PD) deficiency, should discuss risks with their provider, as rifampin may precipitate hemolysis in rare cases.
Rifampin is a potent inducer of several cytochrome P450 enzymes (CYP3A4, CYP2C9, CYP2C19) and the hepatic transporter P-glycoprotein. Consequently, it can reduce plasma concentrations of many co-administered drugs:
Patients should disclose all prescription medications, over-the-counter products, herbal supplements, and dietary habits to their healthcare provider before starting rifampin.
Standard adult dosing for active tuberculosis:
600 mg once daily (either as a single 600 mg pill or the equivalent combination of 300 mg tablets).
The dose may be adjusted to 10 mg/kg (max 600 mg) based on body weight and tolerability.
Prophylactic dosing for meningococcal exposure:
300 mg as a single dose taken orally, preferably on an empty stomach.
Leprosy regimen: Typically 600 mg daily as part of a multidrug combination; dosing duration may extend to 12 months or longer.
Administration tips:
Swallow tablets whole with a full glass of water.
Do not crush or chew the pill unless a liquid formulation is specifically prescribed.
Take the medication on an empty stomach (1 hour before or 2 hours after meals) to maximize absorption.
Missed dose: If a dose is missed, take it as soon as remembered unless it is near the time of the next scheduled dose; do not double up.
Overdose: Symptoms may include nausea, vomiting, abdominal pain, and marked discoloration of bodily fluids. Seek emergency medical care; activated charcoal may be considered if presentation is early.
Discontinuation: Rifampin should generally be stopped under medical supervision. For TB treatment, abrupt cessation can lead to resistance; a full treatment course (usually 6 months) is essential.
Patients should contact their healthcare provider promptly if they notice persistent jaundice, dark urine, unexplained bruising, or severe rash.
This article provides educational information about Rifampin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes. Rifampin is well known for causing a reddish-orange discoloration of urine, sweat, tears, and other bodily fluids. This effect is harmless and typically resolves after the medication is stopped.
Rifampin passes into breast milk in small amounts. While occasional short-term use is often considered acceptable, prolonged therapy should be discussed with a pediatrician, especially for premature infants.
Rifampin induces enzymes that increase the metabolism of estrogen and progestin, reducing contraceptive effectiveness. Women using hormonal birth control should use a non-hormonal method (e.g., barrier or copper IUD) while on rifampin.
Take the missed dose as soon as you remember unless it is almost time for the next scheduled dose. Do not double the dose; instead, continue with the regular dosing schedule and inform your prescriber.
Food, especially fatty meals, can lower the absorption of rifampin by up to 30 %. Taking the pill on an empty stomach (1 hour before or 2 hours after meals) ensures optimal blood levels.
Yes. It is approved for leprosy and for prophylaxis of meningococcal and Hib infections after exposure. Off-label uses, such as surgical site infection prevention, exist but require specialist oversight.
Rifampin is a cornerstone of standard TB therapy, but resistance to rifampin (often linked to isoniazid resistance) defines multidrug-resistant TB (MDR-TB). In such cases, alternative agents or higher-dose rifampin regimens may be considered under specialist guidance.
Baseline liver function tests are recommended before starting therapy, followed by periodic testing (typically every 2 weeks during the intensive phase). Any signs of jaundice or severe fatigue should prompt immediate medical review.
Store the tablets in a cool, dry place away from direct sunlight. If temperatures approach 30 °C consistently, keep the medication in a cabinet rather than in a drawer that may become warm.
Yes. The drug’s color can cause a temporary reddish hue in urine and plasma samples, potentially interfering with certain laboratory assays. Inform the laboratory that you are taking rifampin to avoid misinterpretation.
